Back to Trades
Wein Matthew
InsiderCIK 0002009713
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 6
- Buy transactions
- 0
- Sell transactions
- 5
- Companies
- 1
- Active
- 2025–2026
Across 6 filings between 2025–2026, Wein Matthew has disclosed $247.3K in transactions — all concentrated in Metagenomi Therapeutics, Inc. (MGX). Their disclosed trades are heavily weighted toward selling — $0 in buys and $2.6K in sells. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
6 loaded
| Sep 10 | MGX Metagenomi Therapeutics, Inc. | Wein Matthew | Insider | Sell | $415 |
| Jun 10 | MGX Metagenomi Therapeutics, Inc. | Wein Matthew | Insider | Sell | $725 |
| Apr 3 | MGX Metagenomi Therapeutics, Inc. | Wein Matthew | Insider | Grant | $91.1K |
| Mar 9 | MGX Metagenomi Therapeutics, Inc. | Wein Matthew | Insider | Sell | $771 |
| Dec 8 | MGX Metagenomi, Inc. | Wein Matthew | Insider | Sell | $353 |
| Dec 1 | MGX Metagenomi, Inc. | Wein Matthew | Insider | Sell | $360 |
6 filings